NextGen Group Plc announced that it has made two senior appointments in its NextGen Sciences division, which is focused on protein biomarkers for medical research.
Ruth VanBogelen has been appointed as director of biomarkers and proteomics. Previously, she was director of proteomics for research and development at Pfizer Inc.
Walid Qoronfleh, previously the founder and managing director of the Q3 Consulting Group, has been named vice president of business development.
Source
NextGen Group Plc press release 19 May 2008
Copyright 2008 Evernow Publishing Ltd